August 17, 2016 / 3:27 PM / a year ago

BUZZ-Trillium Therapeutics Inc: Touches more than 2-month high

1 Min Read

** Canadian cancer drug maker's shares up 7.6 pct at 2-month high of C$15.87 mid-morning

** U.S.-listed shares up 6.4 pct at $12.19; also touches 2 month-high of $12.38

** U.S. FDA gives company clearance to proceed with early-stage study of its drug in patients with solid tumors and mycosis fungoides, a common form of skin-related T-cell lymphoma

** Company expects to enroll patients by year-end and initial data in late 2017

** Up to Tuesday's close, Toronto stock had fallen 15 pct this year, while U.S.-listed stock had fallen 9 pct

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below